Rationale for use mefloquine for COVID-19 treatment

Rationale for use mefloquine for COVID-19 treatment

Currently, the use of mefloquine in patients with COVID-19 does not have sufficient scientific justification and, given the unfavorable efficacy and safety profile, cannot be considered for routine use in clinical practice.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kachestvennai͡a︡ klinicheskai͡a︡ praktika 2020-10 (4S), p.103-105
Hauptverfasser: Otdelenov, V. A., Mirzaev, K. B., Dmitriev, A. V., Poroikov, V. V., Sychev, D. A.
Format: Artikel
Sprache:eng ; rus
Schlagworte:
covid-19
коронавирус
мефлохин
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Currently, the use of mefloquine in patients with COVID-19 does not have sufficient scientific justification and, given the unfavorable efficacy and safety profile, cannot be considered for routine use in clinical practice.
ISSN:2588-0519
2618-8473
DOI:10.37489/2588-0519-2020-S4-103-105